Corona Remedies came to market through an IPO that opened on 8 December 2025 and closed on 10 December 2025, and the shares listed on 15 December 2025 on BSE, NSE. The price band was ₹1,008 to ₹1,062 per share and one lot was 14 shares, so the minimum application was ₹14,868. The issue size was ₹655.37 crore. The whole issue was an offer for sale, so the proceeds went to the selling shareholders rather than the company.
Bigshare Services Pvt Ltd was the registrar to the issue, and JM Financial Ltd, IIFL Capital Services Ltd, Kotak Mahindra Capital Co.Ltd were the lead managers.
As of 10 December 2025.
| Day |
|---|
| 1 |
| 2 |
| 3 |
Incorporated in August 2004, Corona Remedies Limited is a pharmaceutical company developing, manufacturing, and marketing products in women's healthcare, cardiology, pain management, urology, and other therapeutic areas.
The diversified portfolio of the company as of December 2024 comprises 67 brands across therapeutic areas such as women's healthcare, cardio-diabeto, pain management, urology, and multispecialty pharmaceuticals, including vitamins/minerals/nutrition, gastrointestinal, and respiratory.The company has a pan-India marketing and distribution network with 2,598 medical representatives in 22 states, enabling effective engagement with healthcare professionals and hospitals, thus consolidating its presence in the IPM and ensuring deep penetration in therapeutic areas.
Presently, the company owns two manufacturing facilities located in the states of Gujarat. As of December 31, 2024, the company had 88 R&D employees.
As described in the offer document.
| Metric | 30-Jun-25 | 31-Mar-25 | 31-Mar-24 | 31-Mar-23 |
|---|
Corona Remedies raises nearly Rs 195 crore from 15 anchor investors. Of the total anchor allotment, 13.59 lakh shares worth Rs 144.4 crore were allotted to 11 domestic mutual funds including SBI Mutual Fund, ICICI Prudential MF, Kotak Mahindra AMC, Axis Mutual Fund, Mirae Asset, Aditya Birla Sun Life AMC, Invesco, DSP MF, Franklin India and Tata MF that have applied through their total of 13 schemes.
The other investors that participated in the anchor book included SBI Life Insurance, Ashoka India, FSSA Indian Subcontinent Fund, and IIFL Asset Management.
Dr. Kirtikumar Laxmidas Mehta, Niravkumar Kirtikumar Mehta, Ankur Kirtikumar Mehta. Promoter holding 72.50% before the issue.
Work out the listing gain for this IPO
If the retail portion is not fully subscribed, every valid application is allotted in full. If it is oversubscribed, SEBI's rules require that as many applicants as possible receive at least one lot, so the shares are allotted by a computerised lottery across all valid applications, one lot each, until the retail portion is exhausted. Applying for more lots does not improve your chance in a lottery; it only increases what you receive if the issue is under-subscribed.
The basis of allotment document, published by the registrar on the allotment date, states the ratio: for example, one applicant in seven received one lot.
Allotment status is published by the registrar on its website, searchable by PAN, application number or demat account, and also on the exchange's website. Allotted shares are credited to the demat account the day before listing, and blocked money for unsuccessful applications is released the same day. The Rupix app can check allotment status by PAN once the registrar publishes it.
Shares list within three working days of the issue closing. On listing day the exchanges run a special pre-open session from nine o'clock, during which orders are collected and an opening price is discovered from them; trading in the share begins after that, usually around ten. The opening price is the listing price that appears on this page once the issue has listed, and the listing gain or loss is the difference between it and the issue price.
For a mainboard issue, the share then trades in the normal way with the exchange's price band for a new listing. For an SME issue, shares trade in lots rather than one at a time, and the market can be thin, so selling on listing day is not always possible at the opening price. Capital gains on shares sold within a year of allotment are short-term and taxed at the short-term rate.
Corona Remedies IPO was a ₹655.37 crore book-built issue, made up entirely of an offer for sale. It was priced at ₹1,008–₹1,062 per share with a lot size of 14 shares (₹14,868). The IPO was open from December 8 to December 10, 2025 and was subscribed 144.49x. Shares listed on BSE and NSE on December 15, 2025 at ₹1,470, a 38.4% premium to the issue price of ₹1,062. Bigshare Services Pvt Ltd is the registrar.
JM Financial Ltd and 2 other book running lead managers manage the issue.
The price band of Corona Remedies IPO is ₹1008 to ₹1062 per share.
The lot size of Corona Remedies IPO is 14 shares.
The minimum investment for Corona Remedies IPO is approximately ₹14,868 based on the upper price band.
The allotment date of Corona Remedies IPO is Dec 11, 2025.
Corona Remedies IPO's final recorded GMP before listing was ₹300 per share (a 28% premium over the ₹1062 upper price band). The shares listed at ₹1470. GMP is unofficial and does not forecast or guarantee the actual listing price.
Corona Remedies IPO listed on Dec 15, 2025. It was issued at ₹1470.0(NSE) and is currently around ₹2155.20 as on 2-Nov-2026 3:30 PM, which is approximately 102.9% versus issue price. The 52-week high is ₹2,292.40.
You can check Corona Remedies IPO allotment status on the registrar or stock exchange websites using your PAN or application number after allotment. You can also check the Corona Remedies IPO allotment status on Rupix for quick and easy access.
₹1,008 to ₹1,062 per share, against a face value of ₹10. Most applicants bid at the cut-off price, the top of the band, so that the application was valid whatever price the issuer finally fixed.
One lot was 14 shares, and every application had to be a whole number of lots. At the top of the band that made the minimum application ₹14,868.
₹14,868, for one lot of 14 shares at the top of the price band. The amount was blocked in the applicant's bank account through ASBA or a UPI mandate while the issue was open, and released on the allotment date to applicants who were not allotted shares.
It opened on 8 December 2025 and closed on 10 December 2025.
The basis of allotment was published on 11 December 2025 by Bigshare Services Pvt Ltd, and allotted shares were credited to demat accounts before listing.
The shares listed on 15 December 2025 on BSE, NSE.
The issue size was ₹655.37 crore. The offer for sale was 61,71,101 shares (aggregating up to ₹655.37 crore).